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Summary 
Notch signaling is critical for T-cell development of multipotent hematopoietic progenitors. 
Yet, how Notch regulates T-cell fate specification during early thymopoiesis remains 
unclear. Here, we have identified an early subset of CD34hi c-kit+ flt3+ IL-7Rα+ cells in the 
human postnatal thymus, which includes primitive progenitors with combined lympho-
myeloid potential. To assess the impact of Notch signaling in early T-cell development, we 
expressed constitutively active Notch1 in such thymic lympho-myeloid precursors 
(TLMPs), or triggered their endogenous Notch pathway in the OP9-Delta-like1 stroma 
coculture. Our results show that proliferation versus differentiation is a critical decision 
influenced by Notch at the TLMP stage. We found that Notch signaling plays a prominent 
role in inhibiting non-T cell differentiation (i.e. macrophages, dendritic cells, and natural 
killer cells) of TLMPs, while sustaining the proliferation of undifferentiated thymocytes 
with T cell potential in response to unique IL-7 signals. However, Notch activation is not 
sufficient for inducing T-lineage progression of proliferating progenitors. Rather, stroma-
derived signals are concurrently required. Moreover, while ectopic IL-7R expression 
cannot replace Notch for the maintenance and expansion of undifferentiated thymocytes, 
Notch signals sustain IL-7R expression in proliferating thymocytes and induce IL-7R 
upregulation in a T-cell line. Thus, IL-7R and Notch pathways cooperate to synchronize 
cell proliferation and suppression of non-T lineage choices in primitive intrathymic 
progenitors, which will be allowed to progress along the T-cell pathway only upon 
interaction with an inductive stromal microenvironment. These data provide insight into a 
mechanism of Notch-regulated amplification of the intrathymic pool of early human T-cell 
progenitors.  
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Introduction 
All mature blood cell types in the adult derive ultimately from a bone marrow 
HSC with self-renewal capacity, which restricts progressively its developmental 
potential through a series of intermediate progenitor stages. Transcription factors and 
cytokines are key regulators of lineage specification of multipotent HSC (1-3). Among 
transcriptional regulators, Notch1, a member of the evolutionarily conserved family of 
Notch transmembrane receptors (4), has recently emerged as a key instructive regulator 
of T-cell commitment and differentiation within the thymus (5, 6). Conditional ablation 
of Notch1 leads to a loss of T cell production and to the development of B cells in the 
thymus (7). Conversely, over-expression of a constitutively active form of Notch1 
inhibits B lymphopoiesis and results in the appearance of developing T cells in the BM 
(8). Thus, Notch1 signaling appears to instruct T-cell commitment at the expense of B-
cell differentiation in thymus-seeding progenitors with T and B potential (9-10). 
However, both human and mouse thymus-settling precursors retain other non-T lineage 
potentials, including NK cell, DC, and even macrophage potential (11-18). 
Consequently, the question that arises is how is Notch-induced T-cell fate specification 
of such multipotent precursors regulated during early thymopoiesis.  
In both humans and mice, the most immature T-cell precursors are included in 
the CD4− CD8− double negative (DN) thymocyte subset. Human DN thymocytes 
contain a minor population of CD34hi CD33+ precursors, which retain lymphoid and 
myeloid lineage potential and express the highest levels of CD34, supporting the notion 
that this population represents the earliest T-cell precursor (14-15). Such CD34hi CD33+ 
thymocytes develop along lymphoid (T/NK) or myeloid (macrophages/DCs) pathways 
through separate intermediate progenitors (19), suggesting that they map to a critical 
precursor stage upstream of the lymphoid/myeloid bifurcation within the thymus. In 
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fact, lymphoid commitment and loss of myeloid potential occurs in downstream CD34+ 
CD33− CD1a−  progenitors (termed pro-T cells), which are conventional T/NK 
bipotential intermediates, and NK cell potential is lost afterward in more mature CD34+ 
CD33− CD1a+  (pre-T) cells, with CD1a expression correlating with T-lineage 
specification (18). However, TCRβ gene rearrangement, a hallmark of T-lineage 
commitment, is delayed in vivo until the next stage of CD4+ immature single positive 
(ISP) thymocytes, which undergo β-selection, differentiate into conventional 
CD4+CD8+ double positive (DP) thymocytes, and lose the potential to generate any 
progeny cell types but T cells (18, 20, 21). Whether both loss of non-T cell potentials 
and commitment to the T cell lineage occur through separate or linked mechanisms 
dependent on Notch1 signaling remains contentious and needs to be directly 
approached.  
Besides endogenous transcription factors, cytokines are important exogenous 
factors capable of regulating hematopoietic development. Lineage-specific action of 
cytokines relies mostly on their survival and proliferation effects on specific 
intermediate progenitors, and seems to be regulated at the level of receptor expression. 
In fact, downregulation of cytokine receptors that drive myeloid development, such as 
the GM-CSFR, and upregulation of the IL-7R represent a critical step in murine 
lymphoid commitment (22). Also, lymphoid and myeloid intermediates in the human 
thymus express respectively the IL-7R or the GM-CSFR (19). Previous results in mice 
showed that the IL-7/IL-7R pathway plays a conserved nonredundant role in early 
thymopoiesis by supporting the survival and proliferation of DN precursors (23 and 
reviewed in 24).  However, whereas thymocyte expansion prior to T-cell commitment is 
driven by IL-7R signals, IL-7 is not required for differentiation beyond the DN2 pre-T 
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cell stage (25). Accordingly, IL-7R levels are tightly regulated during murine T-cell 
development, such that expression of IL-7Rα declines after the DN2 stage, and IL-7R 
signaling must be terminated before transition to the DP stage (25, 26). Besides this 
prominent role of IL-7 in T-cell development, IL-7R signaling is dispensable for NK-
cell and DC development in both humans and mice, and even for B-cell development in 
humans (23, 25, 27) 
Although much is known about the importance of Notch1 and IL-7R signaling in 
T-cell development, the necessary steps that precede T-cell commitment very early in 
intrathymic differentiation remain elusive. In this study we have identified a subset of 
CD34hi  CD33+ c-kit+ flt3+ IL-7Rα+ primitive precursors in the human postnatal thymus, 
and have approached the interplay between Notch1 and IL-7R at this early 
developmental stage. Our results suggest that Notch1 and IL-7R pathways cooperate to 
serve an essential aspect of T-cell development; i.e. amplification of the pool of 
intrathymic progenitors prior to T-cell development.  
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Materials and Methods 
Cell isolation and flow cytometry. 
Human postnatal thymocytes were isolated from thymus fragments removed during 
corrective cardiac surgery of patients aged 1 mo to 4 years, after informed consent was 
provided. Thymocyte suspensions were depleted of Lin-positive cells by MACS 
(AutoMACS, Miltenyi Biotech). TLMPs (CD34hi CD33+ CD1a-), pro-T (CD34+ CD33- 
CD1a-), and pre-T cells (CD34+ CD33- CD1a+) were AutoMACS sorted from the Lin- 
fraction or sorted in a FACSVantage SE sorter (BD Biosciences) as described (19). 
ICN1+ Lin- and GFP+ NK cells generated from TLMPs under multilineage-supportive 
cytokines (see below), were sorted based on GFP, CD13 and CD56 expression. Sorted 
populations were >99% pure upon reanalysis. 
The following directly labeled mAbs were used: CD7-TC, CD8α-PE, CD45RA-
PE, CD15-PE, CD56-PE, and TCRγδ-TC from Caltag; CD1a-APC, CD3ε-PE or -APC, 
CD14-FITC or -PE, CD19-PE, CD34-FTIC or -PE, CD44-FITC, c-kit-APC, flt3-PE, 
and CD161-PE from BD Biosciences; and CD1a-RD1, CD4-PE-Cy5, CD13-PE-Cy5, 
CD33-PE-Cy5, CD34-PE-Cy5, CD56-PE-Cy5, GM-CSFRα-PE, IL-2Rβ-PE, IL-7Rα-
PE, and TCRαβ-PE-Cy5 from Beckman Coulter. PE-, or APC-conjugated goat anti-
mouse F(ab2)’ IgG were from Southern Biotechnology and BD Biosciences, 
respectively. Unlabelled mAbs used were CD2 from BD Biosciences, IL-2Rβ from 
Nichirei, IL-7Rα from Beckman Coulter, and glycophorin from the ATCC. Four- and 
three-color flow cytometry was performed using an EPICS XL (Beckman Coulter) or a 
FACSCalibur (BD Biosciences) cytometer, respectively. Data were collected on viable 
cells. Propidium iodide staining was used to exclude dead cells. Isotype-matched 
irrelevant antibodies (Caltag) were used to define background fluorescence.  
  
 7
Retroviral constructs and cell transduction. 
The retroviral vectors encoding the entire ICN1 domain and GFP from a bicistronic 
transcript (MigR1-ICN1), or GFP alone (MigR1-GFP), were provided by Dr. J.C. Aster 
(28). Previous studies validated the use of GFP as a surrogate marker for ICN1 
expression and confirmed successful ICN1 expression by western blotting (8, 29). Full-
length cDNA encoding human IL-7Rα was amplified by PCR from human thymocytes 
and subcloned into the MigR1-GFP plasmid. Specific expression of IL-7Rα on GFP+ 
cells was confirmed by intracellular staining in transiently transfected COS cells. 
Retroviral infections were performed as described (29).    
 
Cell cultures.  
DC and monocytes were generated from TLMPs in RPMI 1640 (BioWhittaker) cultures 
supplemented with 10% FCS (Invitrogen) and the following recombinant human (rh) 
cytokines from the National Institute of Biological Standards and Controls (NIBSC): 
100 IU/ml of IL-7, 60 IU/ml IL-1α, 50 IU/ml IL-6, 100 IU/ml SCF, and 100 IU/ml GM-
CSF (referred to as myeloid/DC-supportive cultures). Addition of 50 IU/ml IL-2 
(Hoffman La Roche) or 50 IU/ml IL-15 (NIBSC) to those cultures (multilineage-
supportive cultures) allowed for the simultaneous generation of NK cells.  
 CFU assays were performed by plating 103-3x104 TLMPs per ml in Methocult 
GF (StemCell Technologies) containing 30% FCS and supplemented with 100 ng/ml 
SCF, 10ng /ml IL-3, and 10 ng/ml GM-CSF (NIBSC). Colonies were counted by day 
14. GM-CFU identification was based on typical morphology and flow cytometry of 
individual colonies. 
 The OP9 murine BM stroma cell line expressing either GFP (OP9) or the Notch 
ligand Delta-like1 (OP9-DL1) was kindly provided by Dr. J.C. Zúñiga-Pflücker. OP9 
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cocultures were performed as originally described (30) in the presence of either 
multilineage-supportive cytokines (see above) or 100 IU/ml of rhIL-7 (NIBSC; specific 
activity: 108 IU/mg) plus 50 IU/ml rhFlt3-L (NIBSC; specific activity: 106 IU/mg). 
When indicated lower amounts (20 or 5 IU/ml) of rhIL-7 were used.  
Hybrid human/mouse fetal thymic organ cultures (hu/mo FTOC) were 
performed as described (29). 
 
Semiquantitative RT-PCR and TCRβ gene rearrangements. 
Total RNA isolated using Trizol (Invitrogen) was reverse transcribed into cDNA using 
oligo-d(T) primer and Expand Reverse Transcriptase (Roche). PCR reactions, 
performed using the same serially diluted cDNA samples shown for β-actin, were 
subjected to 1.5-2% agarose electrophoresis and visualized with ethidium bromide. The 
gene-specific primers, product lengths, and amplification conditions used are provided 
in Table 1.  
The V(D)J and DJ TCRβ gene rearrangement analysis was performed by PCR and 
Southern blotting as previously described (20). 
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Results 
Characterization of c-kit+ flt3+ IL-7Rα+ progenitors with lympho-myeloid potential 
in the human postnatal thymus.  
CD34+ CD44+ CD1a− Lin− immature human thymocytes include up to 35% of CD33+ 
cells, which express the highest CD34 surface levels (CD34hi) (Fig.1A) Such CD34hi 
CD33+ subset (0.030±0.018% of total thymocytes) includes primitive progenitors with 
the capacity to generate NK cells, myeloid and plasmacytoid DCs, and even 
monocyte/macrophages, in addition to T cells, suggesting that they comprise the earliest 
progenitors seeding the human postnatal thymus (18,19). The myeloid potential of 
CD34hi CD33+ thymocyte precursors was validated in conventional methylcellulose 
colony-forming assays (Fig. 1B) showing that clonogenic colonies with a typical GM 
morphology were formed at frequencies lower than those of HSC (13), but higher than 
expected for an intrathymic precursor (Table 2). Phenotypic analysis of individual 
colonies confirmed the generation of CD14+ macrophages, CD15+ granulocytes and 
CD14− CD13+ CD1a+ myeloid DCs (data not shown). As a whole, available data showing 
that CD34hi CD33+ thymic precursors display a robust T cell developmental capacity 
(29), include NK/DC clonogenic precursors (15), and can generate GM lineage cells (Fig. 
1B), provide evidence that thymus-seeding cells retain lymphoid and myeloid potential. 
Therefore, they will be hereafter referred to as thymic lympho-myeloid precursors or 
TLMPs.  
 More extensive phenotypic analyses showed that virtually all TLMPs, isolated by 
means of CD34 and CD33 expression, expressed the c-kit and flt3 receptors as well as low-
to-intermediate levels of IL-7Rα (Fig. 1A). Increased IL-7Rα and decreased c-kit and flt3 
expression was found on downstream CD34+ CD33− pro-T and CD34+ CD1a+ pre-T cells 
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(Fig. 1A), whereas no expression of myeloid-lineage cytokine receptors such as GM-
CSFRα could be detected on TLMPs, pro-T or pre-T cells (Table 3). Therefore, human 
TLMPs display a c-kit+ flt3+ IL-7Rα+ phenotype (Fig. 1A), equivalent to that recently 
described for lympho-myeloid stem cells in the BM (31) and thymus-settling cells in mice 
(9). 
 
Activation of Notch1 signaling inhibits myeloid differentiation of human TLMPs.  
To investigate the role of Notch1 in the regulation of the earliest cell fate decisions in the 
human thymus, TLMPs were retrovirally transduced with a bicistronic vector encoding a 
constitutively active form of Notch1 and GFP as a reporter (ICN1+), or GFP alone 
(GFP+), as a control. Both GFP- and  ICN1-transduced TLMPs were then assayed for 
their myeloid potential in vitro under myeloid/DC-supportive differentiation conditions 
(IL-7, SCF, IL-1α, IL-6, GM-CSF) shown previously to sustain the simultaneous 
generation of CD14+ CD13+  monocyte/macrophages and CD14− CD13+ myeloid DCs 
which express CD1a (19). As shown in Figure 2A, a marked reduction in both 
frequencies  and numbers of DCs was found in ICN1+ cultures as compared with GFP+ 
controls (mean + SEM; 10.0 + 3.9-fold and 6.2 + 0.2-fold reduction, respectively, in 3 
independent experiments). The impaired generation of DCs correlated with a 10.6 + 
1.6-fold decrease of macrophages (Fig. 2B), indicating that Notch1 signaling inhibited 
the differentiation of TLMPs into myeloid-lineage cells. Inhibition of myeloid 
differentiation was not due to a decreased cell survival of ICN1-transduced progenitors. 
Instead, Notch signaling supported the expansion in vitro of thymocytes blocked to 
myeloid fates up to day 16-18, but then the culture declined steadily (Fig. 2A). Therefore, 
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activation of the Notch pathway impairs myeloid/DC differentiation of TLMPs, while 
supporting the expansion in vitro of thymocyte precursors blocked to myeloid fates. 
 
Sustained Notch1 activation impairs NK cell differentiation at sequential 
intrathymic precursor stages.  
To assess the impact of Notch-1 signaling on NK cell fate, ICN1-transduced TLMPs 
were next analyzed for their differentiation potential in myeloid/DC-supportive cultures 
supplemented with IL-2 (or IL-15), which are permissive for multilineage 
(myeloid/DC/NK) differentiation (15). GFP-transduced TLMP controls gave rise within 8 
days to an early wave of CD13+ CD7− myeloid cells, including DCs (15, 19), followed by 
a second wave of CD13− CD7+ CD56+ NK cells, which became the predominant 
population by day 15-18 of culture (Fig. 3A). In contrast, sustained Notch1 signaling 
abrogated myeloid/DC differentiation, and also resulted in a marked reduction of 
frequencies and numbers of NK cells (8.4 + 0.8- and 8.7 + 1.9-fold, respectively, in 6 
independent experiments) (Fig. 3A, B). Notably, ICN1+ thymocytes blocked to 
myeloid/DC/NK non-T cell fates proliferated in vitro with kinetics parallel to those of 
GFP+ controls (Fig. 3A). Inhibition of NK cell differentiation induced by Notch1 was not 
specific of thymic precursors at the TLMP stage. Rather, Notch1 signaling also resulted 
in a marked reduction of frequencies and numbers (25.6 + 4.2- and 23.4 + 4.3-fold, 
respectively) of NK cells derived from downstream CD34+ CD44+ CD33− T/NK 
bipotential progenitors at the pro-T cell stage, while supporting their expansion  in vitro 
(Fig. 3C, D). Therefore, Notch1 signaling impairs early thymocyte progenitors at 
successive developmental stages from adopting an NK cell fate, but supports their 
proliferation in vitro.  
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Sustained Notch 1 signaling is capable of inhibiting non-T cell differentiation, but is 
not sufficient for inducing progression along the T-cell lineage.  
Flow cytometry analyses were then performed to phenotypically characterize ICN1+ 
thymocytes proliferating under multilineage-differentiation conditions. Results 
summarized in Table 3 showed that ICN1+ thymocytes displayed a CD2+ CD7+ 
CD45RA+ lymphoid-associated phenotype, kept expression of c-kit and flt3, but 
upregulated surface IL-7Rα and cytoplasmic CD3ε expression levels, as compared with 
TLMPs. Also, they turned off CD33 and CD34 molecules expressed on primary TLMPs. 
Notably, no lineage markers (including erythroid, myeloid, NK, B and T cells) were 
expressed throughout culture on ICN1+ Lin− thymocytes.  Neither did they express the 
typical CD1a T-lineage marker induced at the pre-T cell stage, or the CD4 molecule, 
which marks the onset of TCRβ gene rearrangements in human T-cell development (18). 
As a whole, the phenotype ICN1+ Lin− cells matches that of lymphoid-committed 
intrathymic precursors at the pro-T cell stage. Notably, the same phenotype was 
displayed by pro-T cells transduced with active Notch1 (data not shown).  
To approach the lineage affiliation of ICN1+ Lin− proliferating thymocytes at the 
molecular level, we next focused on expression analysis of lineage-associated regulatory 
genes (32). As shown in Figure 4A, RAG-1, a hallmark of lymphoid commitment which 
is upregulated in vivo at the TLMP to pro-T cell transition (20), was turned on in 
ICN1+ Lin- thymocytes, whereas the myeloid-related transcription factor C/EBPα , which 
is downregulated in pro-T cells, was decreased in ICN1+ Lin− thymocytes as well. Cells 
overexpressing active Notch1 also showed a marked reduction of GATA2, which is 
repressed in vivo in pro-T and pre-T cells, while PU.1 expression remained unaffected. 
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Notably, transcription factors that influence T-cell commitment and early T-cell 
differentiation such as HEB, GABPα, and GATA3, as well as the T-lineage gene pTα, 
were expressed in vivo in primary TLMPs and were maintained in vitro in ICN1-
transduced precursors, while none of these genes but GATA3 was expressed in NK cells 
derived from TLMP GFP+ controls (Fig. 4A). Finally, Notch downstream targets Hes1 
and Deltex1 were expressed in TLMPs (Fig. 4A), suggesting that Notch signaling is 
active in vivo in some progenitors included within this early precursor subset. Taken 
together, our phenotypic and genetic studies suggest that ICN1+ Lin− proliferating 
thymocytes are blocked at the pro-T cell stage.   
Notch signaling is required for proper TCRβ gene rearrangement (33), which 
marks irreversible commitment to the αβ T cell-lineage. Analyses on the rearrangement 
status of the TCRβ locus revealed that ICN1+ Lin− undifferentiated thymocytes displayed 
a TCRβ germ-line configuration, as they lacked not only V(D)Jβ, but also DJβ 
rearrangements (Fig. 4B). Neither did they express TCRγ or TCRδ gene products (not 
shown) indicative of T-lineage commitment. Therefore, we concluded that sustained 
Notch1 signaling is necessary and sufficient for inhibiting differentiation of thymocyte 
precursors into non-T (myeloid, DC, and NK) cell fates, but is not sufficient for inducing  
TCR gene rearrangement and progression along the T-cell lineage. However, ICN1+ Lin−  
undifferentiated thymocytes could develop into conventional DP thymocytes in a hu/mo 
FTOC system, although less efficiently than freshly-isolated TLMPs (Fig. 4C), this 
providing functional evidence that they display T-cell differentiation potential.  
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Constitutive Notch1 activation is permissive for expansion of thymocyte precursors, 
but does not substitute for survival and proliferation signals provided by IL-7.  
We found that maintenance of IL-7Rα surface expression was a key feature of ICN1+ 
thymocytes proliferating in vitro (Table 3 and Fig. 5A). In contrast, control TLMPs 
differentiating into NK cells and myeloid cells lost IL-7Rα  and simultaneously 
upregulated either IL-2Rβ, a hallmark of NK cell commitment (34), or GM-CSFRα, a 
myeloid-lineage marker (22), respectively, but these cytokine receptors were never 
coexpressed in ICN1+ thymocytes (Fig. 5A and Table 3). To address whether 
maintenance and upregulation of IL-7Rα expression is a by-product of progression 
toward the T-cell lineage or is directly induced by Notch, we assessed the impact of 
Notch1 signalling on IL-7Rα expression at the clonal level in the T-cell line Jurkat. As 
shown in Figure 5B, surface expression of IL-7Rα was markedly upregulated (13-fold) in 
ICN1-transduced Jurkat cells, and IL-7Rα upregulation (5-fold increase) was observed as 
well in IL-7Rα-transduced Jurkat cells, included as a control. Collectively, these results 
support the possibility that activation of the Notch pathway is involved in the regulation 
of IL-7R surface expression in developing human thymocytes. 
IL-7 is known to serve a nonredundant survival and proliferative function in early 
T-cell development (26, 27). Therefore, we investigated whether the IL-7/IL-7R pathway 
was functionally involved in proliferation of ICN1+ undifferentiated thymocytes. As 
shown in Figure 5C, ICN1+ Lin− thymocytes proliferated exponentially with a 1.5-day 
doubling time in multicytokine cultures up to day 20, and cellular recovery declined 
thereafter. However, ICN1+ Lin− cell numbers were markedly reduced in cultures 
deprived of IL-7 by day 9. In fact, ICN1+ Lin− thymocytes kept viable for 5-6 days upon 
IL-7-withdrawal, but cell viability dropped severely afterwards. Therefore, survival and 
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proliferation of ICN1+ Lin− precursor thymocytes was supported by nonredundant IL-7 
signals. In contrast, proliferation of NK cells derived from GFP-transduced TLMPs was 
IL-2-dependent, but independent of IL-7 (Fig. 5C). These results provide evidence that 
Notch1 signaling does not substitute for survival and proliferation signals provided by IL-
7R.  
To investigate the impact of IL-7R signaling on the developmental fate of human 
TLMPs, we next analyzed the differentiation potential of TLMPs retrovirally transduced 
with IL-7Rα (Fig. 6A). In contrast to ICN1+ TLMPs, IL-7Rα-transduced TLMPs 
differentiated toward myeloid DCs and NK cells with kinetics and efficiencies similar to 
GFP-transduced controls (Fig. 6B). Developing non-T cells upregulated the expected 
cytokine receptor (GM-CSFRα and IL-2Rβ, for myeloid and NK cells, respectively) and 
coexpressed IL-7Rα (Fig. 6C), but proliferated independently of IL-7 (Fig. 6D). In 
contrast, ectopic IL-7Rα expression was functional in T-lineage cells, as it improved 
cellular recoveries of both αβ and γδ T cells in FTOC supplemented or not with 
exogeneous IL-7 (not shown). Taken together, our results indicate that the IL-7R pathway 
does not influence the lineage fate of TLMPs, but provides unique survival and 
proliferation signals to early thymocyte precursors that have lost the potential to generate 
non-T cells in response to Notch1 signaling.  
 
Notch and OP9 stroma-derived signals are concurrently required for inducing 
progression along the T-cell lineage of proliferating thymic progenitors blocked to 
non-T cell fates. 
To next approach the impact of endogenous Notch signaling in early human thymocyte 
development, we used the reported OP9-DL1 ligand-dependent Notch activation assay 
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(30). In the absence of Notch ligand, OP9 stromal cells allowed TLMPs to differentiate 
simultaneously into myeloid DCs, monocytes and NK cells under multilineage-
supportive cytokine conditions  (Fig. 7). Myeloid cells reached maximal proportions by 
day 8 (Fig. 7A), but decreased progressively thereafter and disappeared by day 12, when 
NK cells became the major cell population (Fig. 7B). In contrast, TLMPs cocultured on 
OP9-DL1 stroma supplemented with multicytokines failed to differentiate along non-T 
cell pathways (10.7 + 1.7- and 10.7 + 2.1-fold reduction in myeloid and NK cell 
production, respectively), but gave rise to CD7+ CD13− lymphoid cells, which 
upregulated the CD1a T-lineage-associated marker (Fig. 7A) and progressed to DP 
thymocytes (see below; Fig. 8B). Kinetic analyses were then performed to assess the 
impact of ligand-induced Notch signaling on the generation of specific intermediate 
progenitors for T or non-T intrathymic differentiation pathways (19). We found that OP9 
cocultures supported the generation of recognizable Lin− myeloid progenitors with 
upregulated CD44 and downregulated CD34 expression (CD34int CD44hi), which have 
lost surface IL-7Rα  (Fig. 8A). Such myeloid precursors increased progressively in OP9 
cultures up to day 7, while CD34hi CD44hi TLMPs decreased concurrently (Fig. B). In 
marked contrast, generation of myeloid progenitors was very inefficient in OP-9-DL1 
cocultures (3.7 + 0.7-fold reduction in absolute numbers), whereas Lin− CD34int 
CD44lo pro-T cells with upregulated IL-7Rα were efficiently generated (7.4 + 0.6-fold 
increased numbers) (Fig.8A). Strikingly, the OP-9-DL1 coculture supported the 
expansion of undifferentiated pro-T cells for about one week (14.4 + 1.4-fold from day 3 
to day 7). Thereafter, pro-T cells differentiated into CD1a+ pre-T cells, which were also 
11.6 + 0.8-fold expanded during the next 1-week culture period, and then they gave rise 
to DP thymocytes (Fig. 8B). More importantly, we found that pro-T and pre-T cells 
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coexisted with constant numbers of CD34hi CD44hi undifferentiated TLMPs in OP9-DL1 
cultures during the first week of culture, whereas neither TLMPs, nor T-lineage cells 
survived in the OP9 coculture (Fig. 8B). Therefore, Notch signaling not only supports the 
proliferative expansion of human thymocytes developing throughout successive T-cell 
maturation stages, but is also permissive for the maintenance of T-cell precursors.  
Further experiments performed under conventional cytokine conditions for OP9-
DL1 cocultures (i.e. IL-7 plus Flt-3L) (30) revealed that progression along the T-cell 
lineage proceeded with efficiencies equivalent to those observed in multicytokine-
supplemented OP9-DL1 cocultures (Fig. 8C and data not shown). However, we 
consistently found that T-cell development was more efficient both in absolute and 
relative terms in the FTOC system (Fig. 4C). In this regard, it has been shown that IL-7 
concentrations are critical for efficient T-cell development of murine postnatal 
precursors, which is greatly improved in the OP9-DL1 coculture by lowering IL-7 
amounts (35, 36). In contrast, we found that lowering IL-7 in our conventional OP9-DL1 
cocultures from 100 IU/ml to 20 or 5 IU/ml did not result in enhanced T-cell production. 
Neither, did we observe improved T-cell recoveries when OP-DL1 cocultures initiated 
and maintained for the first 12 days with 100 IU/ml rhIL-7 were subcultured with lower 
IL-7 amounts. Rather, both total cell numbers and T-cell production dropped severely in 
OP9-DL1 cultures following IL-7-lowering (Fig. 8C and data not shown). Survival of 
TLMPs and proliferation of pro-T and pre-T cells dropped as well (data not shown)  
Collectively, our results indicate that both constitutive and ligand-induced Notch 
signaling suppress the generation and/or expansion of non-T lineage precursors from 
TLMPs, and thus impairs the development of myeloid and NK cell lineages, while 
simultaneously supporting the maintenance and expansion of progenitors with T-cell 
potential. However, progression of proliferating progenitors along the T-cell pathway is 
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only supported by ligand-induced Notch signaling in the OP9-DL1 coculture. To address 
whether physiological Notch/Delta signaling is the rate-limiting event for inducing T-cell 
differentiation in the OP9-DL1 coculture, TLMPs overexpressing constitutive active 
Notch1 were analyzed for their T-lineage potential upon coculture onto OP9-control 
stroma. As shown in Figure 8D, ICN1+ thymocytes, but not GFP-transduced TLMPs, 
progressed along the T-cell pathway and gave rise to CD1a+ IL-7Rα+ pre-T cells when 
cocultured with OP9 cells. These results suggest that stroma-derived inductive signals are 
required besides Notch signaling for supporting early thymic precursors blocked to non-T 
cell fates to progress along the T-cell pathway  
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Discussion 
Hematopoietic precursors commit and differentiate to the T-cell lineage in response to 
instructive Notch1 signals delivered intrathymically (5, 6, 9, 10). An intriguing aspect of 
T-cell development is that commitment occurs relatively late after thymus entry, in 
progenitors that have already spent about two wks within the thymus and have undergone 
a 103-fold expansion, mostly driven by IL-7R signals (22, 24). Here we have approached 
the role that Notch1 signaling may play during this particular window that covers the 
initial steps of T-cell development. By combining ligand-independent and Delta-like1-
induced endogenous Notch activation, we show that the most prominent function of 
Notch1 signaling in very early T-cell development is to block non-T cell differentiation 
of primitive intrathymic progenitors, while maintaining the proliferation of T-cell 
precursors. However, Notch signaling is not sufficient to promote terminal T-cell 
differentiation, but requires additional stromal-derived signals. Notably, Notch1-induced 
proliferation was shown dependent on IL-7R signaling, but ectopic IL-7R expression 
could not replace Notch1 for the maintenance and expansion of progenitors blocked to 
non-T cell fates. Thus, we conclude that the concerted activation of both Notch1 and IL-
7R pathways may serve an essential function of amplification of the intrathymic pool of 
T-cell progenitors, prior to inducing their terminal T-cell differentiation in response to 
instructive signals provided by the thymic microenvironment.  
Previous studies have shown that the human thymus contains primitive 
progenitors with combined lymphoid an myeloid potential (14, 18, 19), suggesting  that, 
as recently shown in mice (9, 10, 11, 36), recent thymus immigrants in man include 
multipotent progenitors distinct from HSCs. Thymic lympho-myeloid progenitors, with 
T, NK, DC and GM potential (referred to as TLMPs), are identified here within a subset 
of Lin- CD34+ thymocytes that express c-kit, flt3, and IL-7 receptors. Although formal 
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proof that such TLMPs include B-cell progenitors is still lacking, this possibility appears 
very likely in light of a recent report showing that CD34+ CD1a- human immature 
thymocytes do in fact include progenitors with B lymphoid potential (13). Immature 
thymocytes expressing ckit and flt3 have also been identified within the early T-cell 
precursor (ETP) population in mice (9). Moreover, c-kit+ flt3+ IL-7Rα+ cells have 
recently been characterized in murine BM as a novel subset of multipotent lympho-
myeloid BM stem cells devoid of  megakaryocyte/erythrocyte (MkE) potential (31). 
These are lymphoid-primed IL-7R+ progenitors with short-term reconstitution potential, 
which seem to define the first lineage commitment/restriction step of a novel route for 
adult HSC development (31, 37). It is thus possible that such short-term HSCs are the 
immediate precursors of multipotent TLMPs. Although formal proof that multilineage 
hematopoietic potential can be attributed to a single TLMP progenitor cell still deserves 
appropriate clonal approaches, the stem cell-like nature of TLMPs is also supported by 
their gene expression profiles, since they still lack RAG1 transcription, but display 
multilineage gene expression, a feature that precedes commitment in the hematopoietic 
system (2, 38). Alternatively, the observed expression of T-lineage-associated genes (i.e. 
GATA-3, HEB and pTα) in TLMPs would suggest that the T-cell program was already 
initiated at this early stage, a possibility that is further supported by the finding of Notch 
target gene expression in TLMPs. High levels of Hes1 transcription are also found in 
murine ETPs, and remain essentially constant up to DN3 stage; however, Deltex1 
expression is upregulated at the next developmental stage in mice (9, 10). Supporting the 
immature feature of human TLMPs, recent data by Rothenberg and coworkers suggest 
that induction of Hes1 transcription and T-lineage gene expression can be temporally 
uncoupled from T-lineage specification in mice (39). 
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Our finding that Notch1-induced T-cell development of human TLMPs occurs at 
the expense of alternative non-T lineage choices, including myeloid, NK cell and DC 
lineages concurs with previous results in mice (10, 16) and extends recent data in humans 
using Notch inactivation approaches (40). In addition, the use of the OP9-DL1 culture 
has provided a new opportunity to show that impaired differentiation of non-T cell 
lineages involves active suppression by Notch. In fact, DL1-mediated Notch signaling 
reduced markedly the generation of intermediate myeloid progenitors from TLMPs, but if 
generated, endogenous Notch activation was also capable of blocking their differentiation 
into macrophages and DCs. A similar suppression mechanism seems to act on 
downstream T/NK pro-T cells to inhibit NK cell differentiation. It is thus possible that 
Notch1 signaling also acts at or immediately upstream of the TLMP stage to block 
intrathymic B-cell differentiation (13), as suggested in mice (9, 10). In this scenario, 
gradual loss of non-T differentiation options induced by Notch could be explained in 
quantitative terms, as recently proposed (40, 41). Thus, increasing thresholds of Notch 
signaling may be required within the thymic microenvironment to sequentially suppress 
B, myeloid/DC and NK cell lineage choices.  
Our results based on constitutive Notch1 signaling in TLMPs indicate that Notch-
dependent suppression of non-T cell differentiation was not linked to progression along 
the T-cell program beyond the pro-T cell stage, although as shown for human HSCs (42), 
nonmanipulated TLMPs undergone T-lineage differentiation in the OP9-DL1 culture. 
While it could be argued that these discrepant outcomes rely on the strong gain of 
function transduction approach used, we found that Lin- ICN1+ cells proliferating 
under multilineage-supportive conditions were capable of progressing along the T-
cell pathway in a FTOC, and ICN1-transduced TLMPs also developed into T cells in 
OP9-control cocultures, or in FTOC. It is thus possible that Notch1 signaling is sufficient 
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for initiating T-lineage specification (i.e. downregulation of myeloid- and progenitor-
associated genes, and RAG1 upregulation), early after thymus seeding, but additional 
inductive signals provided by specific thymic microenvironments, and mimicked by the 
OP9 stroma, are required to promote irreversible T-lineage commitment and terminal T-
cell differentiation. Functional proof that ICN1+ Lin- progenitor cells represent T-
committed progenitors devoid of non-T cell lineage potential must still await the 
development of an inducible ICN expression system.  
An important aspect of our studies is the observation that inhibition of non-T cell 
differentiation by constitutive Notch signaling paralleled a powerful expansion of ICN1+ 
progenitors blocked to non-T cell fates. In addition, endogenous Notch signaling 
provided by the OP9-DL1 stroma supported the maintenance of constant numbers of Lin- 
CD34hi primitive precursors for the first wk of culture , although a marked proliferation 
of progenitors developing throughout the earliest T-cell developmental stages (i.e. pro-T 
and pre-T cells) was concurrently induced. These results point to a critical 
survival/proliferative role of Notch in early T-cell development, and suggest that the 
regulatory function that Notch signaling plays in self-renewal of HSCs and lymphoid and 
myeloid precursors (43-46) can now be extended to the intrathymic pool of T-cell 
precursors. It is thus possible that Notch signaling leads to a short-term maintenance of 
TLMPs blocked for non-T cell fates, while also supporting the expansion of downstream 
pro-T and pre-T cells, likely through asymmetric divisions. This conclusion is further 
supported by previous in vivo and in vitro studies showing that inhibition of Notch 
signaling blocks proliferation of DN mouse thymocytes and human thymic progenitors 
(40, 47). 
As occurs in vivo, survival and expansion induced by Notch in vitro was 
dependent on IL-7R signaling. In contrast, suppression of non-T cell differentiation was 
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not replaced by ectopic IL-7R expression, but required an intact Notch signal. While 
these results do not imply a direct association between Notch and IL-7R, we found that 
TLMPs and also Jurkat T cells upregulate surface IL-7Rα in response to Notch1 
signaling. Moreover, higher IL-7Rα levels can be found in DP ICN1+ thymocytes than in 
their GFP+ counterparts (data not shown). These data, together with the identification of a 
putative CSL binding site in the promoter of the human IL-7Rα gene (not shown) suggest 
that IL-7Rα may be a direct target of Notch in T-lineage cells. Since IL-7R signals are 
critical in early thymopoiesis, but dispensable following T-cell commitment, and must be 
terminated by the DN3 stage (26), it is possible that Notch1 signaling regulates the 
dynamic regulation of IL-7R expression throughout in vivo thymopoiesis (25).In 
summary, we propose that repression of non-T cell differentiation together with delayed 
T-cell differentiation provides a mechanistic basis for how modulation of Notch1 
signaling controls IL-7R-induced expansion of the precursor pool of thymocytes 
throughout development of the T-cell lineage.  
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Figure legends 
Figure 1. Phenotype and GM potential of primitive human CD34+ intrathymic 
progenitors. (A) Flow cytometry analysis of CD34+ thymocytes based on expression of 
CD1a and CD34. Electronic gates of CD34hi CD1a- (a) and CD34+ CD1a+ (b) subsets 
ere performed on magnetically sorted CD34+ Lin- thymocytes. Representative 
histograms for CD33, IL-7Rα, c-kit and flt3 expression in the TLMP (CD34hi CD1a- 
CD33+), pro-T (CD34+ CD1a- CD33-), and pre-T (CD34+ CD1a+ CD33-) CD34+ subsets 
are shown. Shaded histograms represent background fluorescence determined with 
isotype-matched irrelevant mAbs. MFI: mean fluorescence intensity. (B) Bright-field 
images of typical GM colonies generated in vitro from CD34hi CD1a- CD33+ TLMPs by 
day 14 in methylcellulose culture. Original magnification: X100.  
 
Figure 2. Sustained Notch1 signaling impairs myeloid/DC differentiation of human 
intrathymic progenitors. Generation of DCs and monocytes/macrophages from 
TLMPs retrovirally transduced with constitutively active Notch1 and GFP (ICN1), or 
GFP alone (GFP) under myeloid/DC-supportive conditions. (A) Absolute numbers of 
total cells and percentages and absolute numbers of DCs (CD13+ CD1a+) derived from 
ICN1- (□) or mock-transduced (●) TLMPs calculated on electronically gated GFP+ cells 
at the indicated culture times. (B) Representative profiles of CD13 and CD1a expression 
on GFP+-gated progeny of ICN1-transduced or GFP-transduced TLMPs cultured for 9 
days. Background fluorescence was determined with isotype-matched irrelevant mAbs.  
 
Figure 3. Sustained Notch1 signaling prevents NK cell differentiation from human 
thymocyte progenitors at successive developmental stages. Generation of NK cells 
from TLMPs (A and B) or pro-T cells (C and D) overexpressing either activated Notch1 
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(ICN1) or GFP (GFP), under multilineage-supportive conditions. (A) Absolute numbers 
of total cells and percentages and absolute numbers of NK cells (CD56+ CD7+) derived 
from ICN1- (□) or mock-transduced (●) TLMPs or (C) pro-T cells, calculated on 
electronically gated GFP+ cells at the indicated days of culture. (B) Representative 
profiles of CD56 and CD7 expression on GFP+-gated progeny of ICN1-transduced or 
mock-transduced TLMPs cultured for 23 days or (D) pro-T cells cultured for 19 days. 
Numbers represent percentages in each quadrant.  
 
Figure 4. Gene expression, TCRβ gene rearrangement status, and pro-T cell 
potential of human thymic precursors and their ICN1- or GFP-transduced 
progenies. (A) RT-PCR was performed on normalized samples of cDNA (see β-actin) 
either from the TLMP, pro-T and pre-T sorted CD34+ thymocyte subsets described in 
Figure 1, or from progenies of ICN1-transduced (ICN1+ Lin−) and GFP-transduced 
(GFP+ CD56+) TLMPs cultured for 15 days under multilineage-supportive cytokines. 
Twofold serial dilutions of each cDNA were used. (B) Southern-blot analysis of Dβ2-
Jβ2 rearrangements in GFP-sorted ICN1+ Lin- or CD56+ NK cell progenies derived 
from ICN1- or GFP-transduced TLMPs, respectively, after 15 days in multilineage-
supportive cultures. Total thymocytes and K562 myeloid cells served as positive and 
negative controls, respectively. (C) Flow cytometry analysis of CD4 versus CD8 
expression on electronically-gated GFP+ progenies derived by day 28 in FTOC either 
from sorted ICN1+ Lin− thymocytes expanded in vitro under multilineage-supportive 
conditions, or from ICN1- (ICN1) or GFP-transduced (GFP) freshly-isolated TLMPs.  
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Figure 5. Notch1 signaling is essential for maintaining IL-7R surface expression on 
progenies of TLMPs, but does not substitute for survival and proliferation signals 
provided by IL-7. (A) Flow cytometry analysis of IL-7Rα and IL-2Rβ expression in 
GFP+-gated progenies of ICN1-transduced (dashed) and mock-transduced (line) TLMPs 
cultured under multilineage-supportive conditions for the indicated days. Background 
fluorescence (shaded) was determined using isotype-matched irrelevant mAbs. (B) 
Flow cytometry analysis of IL-7Rα expression in GFP+-gated GFP-transduced (GFP), 
IL7Rα-transduced (IL-7Rα), and ICN1-transduced (ICN1) Jurkat T cells.  (C) Absolute 
numbers of ICN1+ Lin- (upper panel) and GFP+ NK cell progenies (lower panel) derived 
from ICN1-transduced and GFP-transduced TLMPs, respectively, either in 
multicytokine-supporting cultures (●) or in multicytokine-supporting cultures deprived 
of either IL-7 (▲) or IL-2 (□) from day 9.  
 
Figure 6. Enforced IL-7Rα expression does not affect the lineage fate of TLMPs. 
TLMPs retrovirally transduced with the human IL-7Rα  subunit and GFP, or GFP 
alone, were cultured under multilineage-supportive conditions. (A) IL-7Rα expression 
on GFP+-gated progeny of IL-7Rα-transduced (dashed) and GFP-transduced (line) 
TLMPs cultured for 12 days. Background fluorescence (shaded) was determined using 
isotype-matched irrelevant mAbs. (B) Percentages of DC and NK cell progenies of 
GFP-transduced (filled bars) or IL-7Rα-transduced (open bars) TLMPs cultured for the 
indicated days. (C) Correlated expression of GM-CSFRα or IL-2Rβ and IL-7Rα on 
GFP+-gated progenies of IL-7Rα-transduced TLMPs cultured for 8 and 12 days, 
respectively. (D) Absolute numbers of total cells recovered from GFP-transduced and 
IL-7Rα-transduced TLMPs cultured under multilineage-supportive conditions either 
with or without IL-7 for the indicated days.  
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Figure 7. Ligand-dependent endogenous Notch activation inhibits myeloid/DC and 
NK cell differentiation of human intrathymic progenitors.  
Generation of (A) DCs and monocytes and (B) NK cells from human TLMPs 
cocultured on either OP9-control or OP9-DL1 stromal cells, under multilineage-
supportive conditions. Flow cytometry analysis of (A) CD13 and CD1a expression and 
(B) CD56 and CD7 expression on progenies of TLMPs cultured for 8 days or 12 days, 
respectively (left histograms). Numbers represent percentages in each quadrant. 
Absolute numbers of DCs (CD13+ CD1a+), monocytes (CD13+ CD1a-), and NK cells 
(CD56+ CD7+) generated in the same OP9-control (filled bars) and OP9-DL1 (open 
bars) cultures are shown on the right. Cell numbers are referred to 105 input progenitors.  
 
Figure 8. Notch and OP9 stroma-derived signals support the survival and 
expansion of early thymic precursors and are concurrently required for inducing 
proliferative thymic progenitors to progress along the T-cell lineage.  
 (A) Correlated expression of CD34 versus CD44 on ex vivo-isolated TLMPs (left dot 
plot) and on the progenies derived from TLMPs by day 7 in OP9 (middle dot plot) and 
OP9-DL1 cocultures (right dot plot) supplemented with multicytokines. Gate a: TLMPs 
(CD34hiCD44hi); gate b:  proT cells (CD34intCD44lo); gate c: myeloid progenitors 
(CD34intCD44hi). Histograms of IL-7Rα expression in progenies derived in OP9 and 
OP9-DL1 cocultures are shown on the right. Background was obtained with isotype-
matched irrelevant controls (shaded histograms). (B) Absolute numbers of total cells, 
TLMPs, myeloid progenitors, proT and preT (CD7+ CD13- CD1a+) cells derived from 
TLMPs in multicytokine-supplemented OP9 and  OP9-DL1 cocultures at the indicated 
times. Cell numbers are referred to 105 input progenitors. The dot plot histogram on the 
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right shows the expression of CD4 versus CD8 on cells recovered from OP9-DL1 
cocultures by day 23. (C) Absolute numbers of total cells derived from TLMPs in OP9-
DL1 cocultures supplemented with the indicated amounts of rhIL-7 plus 50 IU/ml 
rhFlt3-L either for the whole culture period (closed symbols), or for 12 days and then 
changed to lower rhIL-7 amounts (open symbols). Cell numbers are referred to 105 
input progenitors. (D) Absolute numbers of pre-T cells generated from ICN1-transduced 
(ICN1) or GFP-transduced (GFP) TLMPs in OP9-control stroma supplemented with 
100IU/ml rhIL-7 plus 50 IU/ml rhFlt3-L. PreT cell yields were calculated per 105 input 
progenitors. The correlated expression of CD1a and IL-7Rα in cell progenies recovered 
from OP9 cocultures by day 10 is shown in dot plots on the right.  
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Table 1.  Oligonucleotide primers and amplification conditions used for RT-PCR gene expression analysis 
Gene 5’ primer 3’ primer PCR cycles (No.) Size (bp) 
Annealing temperature 
(ºC) 
β-actin GCATGGAGTCCTGTGGCATCCACG GGTGTAACGCAACTAAGTCATAG 20 356 55 
CEBPα GACACGCTGCGGGGCATCT CTGCTCCCCTTCCTTCTCTCA 30 494 55 
Deltex1 AGGGATGACCGGGATACTGC GGCCTTTCTCGTTGTTGGGT 35 632 55 
Ets1 CGATCTCAAGCCGACTCTCA GAGGGTATAGCGGGATTCTGG 35 453 65 
GABPα TCAGCATGACCGATATAGACC GCTGCACTGTATCCAATAAG 30 582 55 
GATA2 TGTTGTGCAAATTGTCAGACG CATAGGTGCCATGTGTCCAGC 35 278 60 
GATA3 GAAGGCATCCAGACCCGAAAC ACCCATGGCGGTGACCATGC 30 254 60 
HEB ACCACTCCATGACTCTGCAGC AGGAGTGTGTGAGGCAGCAAC 30 442 55 
Hes1 GCCAGTGTCAACACGACACCGG TCACCTCGTTCATGCACTCG 30 310 55 
pTα CCCATCTCTCCCTGCCTTCTG GGAGCAGGTCAAACAGCAGC 30 213 55 
PU.1 TGGAAGGGTTTCCCCTCGTC TGCTGTCCTTCATGTCGCCG 35 546 60 
RAG1 CAGCGTTTTGCTGAGCTCCT CTAGGAGAAGCCCTCAATGC 30 455 55 
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Table 2. Myeloid differentiation potential of early 
human thymic precursors 
 
Progenitor No.  
 
CFU-GM a 
  Exp. 1 Exp. 2 Exp. 3 
103  12 4 7 
3x103  24 nd  nd 
104  85 50 67 
3x104  >100 >100 nd 
a The indicated numbers of human CD34+ CD33lo CD1a− thymic 
progenitors were plated in methylcellulose cultures supplemented with 
SCF, GM-CSF, and IL-3. At day 14, the number of GM colonies was 
determined by counting. Data from three independent experiments are 
shown. 
 
Table 3. Comparative phenotype of human CD34+ TLMP, pro-T and pre-T thymic progenitors and the 
progenies derived from GFP-transduced or ICN1-transduced TLMPs cultured under multilineage-
supportive conditions 
 TLMP a  pro-T a  pre-T a  ICN1+ Lin−  b  GFP+ DC c  GFP+ NK c 
CD1a − d  −  +  −  hi  − 
CD2 +  +  +  +  +/−  +/− 
cytCD3 e +/−  +  +  +  −  + 
CD4 −  −  −  −  +  − 
CD7 +  +  +  +  lo  + 
CD33 lo  −  −  −  +  +/− 
CD34 hi  +  lo  −  −  − 
CD45RA +  +  +  +  lo  + 
c-kit +  lo  +/−  +  −  + 
flt3 +  lo  +/−  +  −  + 
GM-CSFR −  −  −  −  +  − 
IL-2Rβ −  −  −  −  −  + 
IL-7Rα lo  +  +  +  −  − 
Flow cytometry was performed on the indicated cell populations. 
a CD34+ CD33lo CD1a− (TLMPs); CD34+ CD33− CD1a− (pro-T cells); CD34+ CD33− CD1a+  (pre-T cells). 
b Lineage-negative (Lin−; CD3−, CD4−, CD13−, CD19−, CD56−, Glycophorin A−) progeny of ICN1-transduced (ICN1+) TLMPs cultured 
under multilineage supportive conditions during 15 days. 
c DC and NK cell progenies of GFP-transduced (GFP+) TLMPs cultured under multilineage supportive conditions for 8 and 15 days, 
respectively. 
d −, negative; +, positive; lo, low expression; hi, high expression; +/−, heterogeneous expression. 
e Cytoplasmic CD3ε. 
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